[Effect of human recombinant erythropoietin therapy on protein metabolism of patients with terminal renal failure on hemodialysis].
Scigalla
P
P
Freie Universität Berlin, Universitätsklinikum Rudolf Virchow, Abteilung für Nephrologie.
Fischer
C
C
Park
W
W
Becker
H
H
Schiller
R
R
Paust
H
H
Brösicke
H
H
Kessel
M
M
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000628:therapy*; D001798:Blood Proteins / Q000378:metabolism*; D002250:Carbon Radioisotopes; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D007930:Leucine; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D006435:Renal Dialysis
D001798:Blood Proteins; D002250:Carbon Radioisotopes; D011994:Recombinant Proteins; D004921:Erythropoietin; D007930:Leucine
Einfluss der rhEPO-Therapie auf den Eiweissstoffwechsel terminal niereninsuffizienter Hämodialysepatienten.